These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 22954333)
41. Inhibition of amyloid beta-peptide production by blockage of beta-secretase cleavage site of amyloid precursor protein. Na CH; Jeon SH; Zhang G; Olson GL; Chae CB J Neurochem; 2007 Jun; 101(6):1583-95. PubMed ID: 17542811 [TBL] [Abstract][Full Text] [Related]
42. Liquid chromatographic enzymatic studies with on-line Beta-secretase immobilized enzyme reactor and 4-(4-dimethylaminophenylazo) benzoic acid/5-[(2-aminoethyl) amino] naphthalene-1-sulfonic acid peptide as fluorogenic substrate. De Simone A; Seidl C; Santos CA; Andrisano V J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():108-14. PubMed ID: 24590190 [TBL] [Abstract][Full Text] [Related]
43. Beta-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors. Mancini F; De Simone A; Andrisano V Anal Bioanal Chem; 2011 Jun; 400(7):1979-96. PubMed ID: 21503735 [TBL] [Abstract][Full Text] [Related]
44. Synthesis and SAR of bis-statine based peptides as BACE 1 inhibitors. Hu B; Fan KY; Bridges K; Chopra R; Lovering F; Cole D; Zhou P; Ellingboe J; Jin G; Cowling R; Bard J Bioorg Med Chem Lett; 2004 Jul; 14(13):3457-60. PubMed ID: 15177452 [TBL] [Abstract][Full Text] [Related]
45. Synthesis, in vitro biological evaluation and molecular docking studies of benzimidamides as potential BACE1 inhibitors. Niu Y; Gao H; Xu F; Wang C; Liu P; Yang G; Sun Q; Xu P Chem Biol Drug Des; 2012 Nov; 80(5):775-80. PubMed ID: 22882897 [TBL] [Abstract][Full Text] [Related]
46. Fluorogenic assay and live cell imaging of HIV-1 protease activity using acid-stable quantum dot-peptide complex. Choi Y; Lee J; Kim K; Kim H; Sommer P; Song R Chem Commun (Camb); 2010 Dec; 46(48):9146-8. PubMed ID: 21049123 [TBL] [Abstract][Full Text] [Related]
47. beta-secretase inhibitory effects of furanocoumarins from the root of Angelica dahurica. Marumoto S; Miyazawa M Phytother Res; 2010 Apr; 24(4):510-3. PubMed ID: 20041416 [TBL] [Abstract][Full Text] [Related]
48. Design, synthesis, and qualitative structure-activity evaluations of novel β-secretase inhibitors as potential Alzheimer's drug leads. Al-Tel TH; Semreen MH; Al-Qawasmeh RA; Schmidt MF; El-Awadi R; Ardah M; Zaarour R; Rao SN; El-Agnaf O J Med Chem; 2011 Dec; 54(24):8373-85. PubMed ID: 22044119 [TBL] [Abstract][Full Text] [Related]
49. Small-molecule ligands strongly affect the Förster resonance energy transfer between a quantum dot and a fluorescent protein. Zhang Y; Zhang H; Hollins J; Webb ME; Zhou D Phys Chem Chem Phys; 2011 Nov; 13(43):19427-36. PubMed ID: 21971088 [TBL] [Abstract][Full Text] [Related]
50. New pyrazolyl and thienyl aminohydantoins as potent BACE1 inhibitors: exploring the S2' region. Malamas MS; Erdei J; Gunawan I; Barnes K; Hui Y; Johnson M; Robichaud A; Zhou P; Yan Y; Solvibile W; Turner J; Fan KY; Chopra R; Bard J; Pangalos MN Bioorg Med Chem Lett; 2011 Sep; 21(18):5164-70. PubMed ID: 21835615 [TBL] [Abstract][Full Text] [Related]
51. Synthesis and biological evaluation of phosphino dipeptide isostere inhibitor of human beta-secretase (BACE1). Manzenrieder F; Frank AO; Huber T; Dorner-Ciossek C; Kessler H Bioorg Med Chem; 2007 Jun; 15(12):4136-43. PubMed ID: 17433698 [TBL] [Abstract][Full Text] [Related]
53. Positively charged compact quantum Dot-DNA complexes for detection of nucleic acids. Lee J; Choi Y; Kim J; Park E; Song R Chemphyschem; 2009 Mar; 10(5):806-11. PubMed ID: 19253931 [TBL] [Abstract][Full Text] [Related]
54. Quantifying RNA-peptide interaction by single-quantum dot-based nanosensor: an approach for drug screening. Zhang CY; Johnson LW Anal Chem; 2007 Oct; 79(20):7775-81. PubMed ID: 17877365 [TBL] [Abstract][Full Text] [Related]
55. Detection of mercury(II) by quantum dot/DNA/gold nanoparticle ensemble based nanosensor via nanometal surface energy transfer. Li M; Wang Q; Shi X; Hornak LA; Wu N Anal Chem; 2011 Sep; 83(18):7061-5. PubMed ID: 21842845 [TBL] [Abstract][Full Text] [Related]
56. A capillary electrophoresis-mass spectrometry based method for the screening of β-secretase inhibitors as potential Alzheimer's disease therapeutics. Schejbal J; Slezáčková L; Řemínek R; Glatz Z J Chromatogr A; 2017 Mar; 1487():235-241. PubMed ID: 28153449 [TBL] [Abstract][Full Text] [Related]
57. Advances in the identification of β-secretase inhibitors. Hamada Y; Kiso Y Expert Opin Drug Discov; 2013 Jun; 8(6):709-31. PubMed ID: 23565721 [TBL] [Abstract][Full Text] [Related]
58. Spatial control of cells, peptide delivery and dynamic monitoring of cellular physiology with chitosan-assisted dual color quantum dot FRET peptides. Fu RH; Liu SP; Ou CW; Huang CM; Wang YC Acta Biomater; 2010 Sep; 6(9):3621-9. PubMed ID: 20215055 [TBL] [Abstract][Full Text] [Related]
59. N-(2-(Piperazin-1-yl)phenyl)arylamide Derivatives as β-Secretase (BACE1) Inhibitors: Simple Synthesis by Ugi Four-Component Reaction and Biological Evaluation. Edraki N; Firuzi O; Fatahi Y; Mahdavi M; Asadi M; Emami S; Divsalar K; Miri R; Iraji A; Khoshneviszadeh M; Firoozpour L; Shafiee A; Foroumadi A Arch Pharm (Weinheim); 2015 May; 348(5):330-7. PubMed ID: 25787800 [TBL] [Abstract][Full Text] [Related]
60. Novel pyrrolyl 2-aminopyridines as potent and selective human beta-secretase (BACE1) inhibitors. Malamas MS; Barnes K; Hui Y; Johnson M; Lovering F; Condon J; Fobare W; Solvibile W; Turner J; Hu Y; Manas ES; Fan K; Olland A; Chopra R; Bard J; Pangalos MN; Reinhart P; Robichaud AJ Bioorg Med Chem Lett; 2010 Apr; 20(7):2068-73. PubMed ID: 20223661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]